Agenus Inc (NAS:AGEN)
$ 14.56 0.99 (7.3%) Market Cap: 305.75 Mil Enterprise Value: 341.77 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 54/100

Q2 2022 Agenus Inc Earnings Call Transcript

Aug 09, 2022 / 12:30PM GMT
Release Date Price: $50.24 (-1.92%)
Operator

Good morning. My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Agenus Second Quarter 2022 Financial Results Conference Call. (Operator Instructions) Thank you. Mr. Ethan Lovell, Chief of External Affairs and Communications Officer, you may begin your conference.

Ethan Lovell
Agenus Inc. - Chief External Affairs & Communications Officer

Thank you. Good morning, everyone, and welcome to our second quarter earnings results conference call. I'm Ethan Lovell, Agenus' Chief External Affairs and Communications Officer, and I have with me today on the call Agenus' Chairman and CEO, Garo Armen; and the company's Vice President of Finance, Christine Klaskin. Also joining us today is the Agenus' Chief Medical Officer, Dr. Steven O'Day, who will be available during the Q&A portion of this call.

Before I turn the call over to Garo for his prepared remarks, I would like to read our forward-looking statement disclosure. This call will include forward-looking statements, including statements

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot